SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-04-000056
Filing Date
2004-01-26
Accepted
2004-01-26 16:55:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 regenerx13dano1-012604.txt SC 13D/A 26608
3 WARRANT A sigmawarranta-ex.txt EX-2 28023
4 WARRANT B sigma13dwarrantb-ex.txt EX-3 28524
5 WARRANT sigma13dwarrant-ex.txt EX-4 28068
  Complete submission text file 0000950162-04-000056.txt   113659
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 04543846
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address VIA SUDAFRICA 20 00144 ROME ITALY
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231